Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures

被引：3
|
作者：
Reguiai, Z. [1 ,20 ]
Becherel, P. A. [2 ]
Fougerousse, A. C. [3 ]
Chaby, G. [4 ]
Perrot, J. L. [5 ]
Begon, E. [6 ]
Jacobzone-Leveque, C. [7 ]
Boulard, C. [8 ]
Badaoui, A. [9 ]
Poreaux, C. [10 ]
David, L. [11 ]
Quiles-Tsimaratos, N. [11 ]
Lons-Danic, D. [12 ]
Fite, C. [12 ]
Liegeon, A. -l. [13 ]
Patchinsky, A. [13 ]
Parier, J. [14 ,15 ]
Garcia, C. [16 ]
Esteve, E. [17 ]
Mohty, R. [18 ]
Mery-Bossard, L. [19 ]
Maccari, F. [3 ,15 ]
机构：
[1] Polyclin Courlancy, Dept Dermatol, Reims, France
[2] Antony Hosp, Dermatol & Clin Immunol Unit, Antony, France
[3] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France
[4] CHU Amiens Picardie, Dept Dermatol, Amiens, France
[5] CHU St Etienne, Dept Dermatol, St Etienne, France
[6] Ctr Hosp Rene Dubos, Dept Dermatol, Pontoise, France
[7] Ctr Hosp Bretagne Sud, Dept Dermatol, Lorient, France
[8] Ctr Hosp Le Havre, Dept Dermatol, Le Havre, France
[9] Cabinet Med, Paris, France
[10] Clin Pasteur, Ctr Dermatol Stanislas, Nancy, France
[11] Hop St Joseph, Dept Dermatol, Marseille, France
[12] Hop Paris St Joseph, Dept Dermatol, Paris, France
[13] Ctr Hosp Reg Metz Thionville, Dept Dermatol, Thionville, France
[14] Hop St Louis, Ctr Sante Sabouraud, Paris, France
[15] Cabinet Med, St Maur Des Fosses, France
[16] Ctr Hosp Emile Roux, Dept Dermatol, Le Puy En Velay, France
[17] Ctr Hosp Orleans, Dept Dermatol, Orleans, France
[18] Cabinet Med, Beauvais, France
[19] CHI Poissy St Germain, Dept Dermatol, St Germain En Laye, France
[20] Polyclin Courlancy Bezannes, Dept Dermatol, 89 Rue Louis Victor Broglie, F-51430 Bezannes, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 11期
关键词：
D O I：
10.1111/jdv.19302
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E1307 / E1309
页数：3
相关论文
共 50 条
  • [31] REAL-LIFE EXPERIENCE IN THE EFFECTIVENESS , IMPACT ON QUALITY OF LIFE AND SAFETY OF DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS IN THE CZECH REPUBLIC
    Tanczosova, Milena
    Kojanova, Martina
    Arenbergerova, Monika
    Arenberger, Petr
    Dolezal, Tomas
    Strosova, Daniela
    Fialova, Jorga
    Gkalpakiotis, Spyridon
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 30 (01) : 46 - 50
  • [32] Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience
    Ferrucci, Silvia
    Barei, Francesca
    Tavecchio, Simona
    Marzano, Angelo V.
    Zussino, Martina
    Naldi, Luigi
    Pezzolo, Elena
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [33] Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort
    Gulle, Semih
    Karakas, Ali
    Can, Gercek
    Senel, Soner
    Capar, Sedat
    Dalkilic, Huseyin Ediz
    Akar, Servet
    Koca, Suleyman Serdar
    Tufan, Abdurrahman
    Yazici, Ayten
    Yilmaz, Sema
    Inanc, Nevsun
    Birlik, Merih
    Solmaz, Dilek
    Cefle, Ayse
    Goker, Berna
    Yolbas, Servet
    Krough, Niels Steen
    Yilmaz, Neslihan
    Erten, Sukran
    Bes, Cemal
    Soysal, Ozgul
    Ozturk, Mehmet Akif
    Haznedaroglu, Seminur
    Yavuz, Sule
    Direskeneli, Haner
    Onen, Fatos
    Sari, Ismail
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 843 - 845
  • [34] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Longo, Giuseppe
    Argenziano, Giuseppe
    Ferrucci, Silvia Mariel
    Stingeni, Luca
    Peris, Ketty
    Ortoncelli, Michela
    Offidani, Annamaria
    Amoruso, Giuseppe Fabrizio
    Talamonti, Marina
    Girolomoni, Giampiero
    Grieco, Teresa
    Iannone, Michela
    Nettis, Eustachio
    Foti, Caterina
    Rongioletti, Franco
    Corazza, Monica
    Veneri, Michele Delli
    Napolitano, Maddalena
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 581 - 586
  • [35] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
    Cataldo Patruno
    Gabriella Fabbrocini
    Giuseppe Longo
    Giuseppe Argenziano
    Silvia Mariel Ferrucci
    Luca Stingeni
    Ketty Peris
    Michela Ortoncelli
    Annamaria Offidani
    Giuseppe Fabrizio Amoruso
    Marina Talamonti
    Giampiero Girolomoni
    Teresa Grieco
    Michela Iannone
    Eustachio Nettis
    Caterina Foti
    Franco Rongioletti
    Monica Corazza
    Michele Delli Veneri
    Maddalena Napolitano
    American Journal of Clinical Dermatology, 2021, 22 : 581 - 586
  • [36] Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase®, the WHO Pharmacovigilance Database
    Cellier, Morgane
    Bourneau-Martin, Delphine
    Abbara, Chadi
    Crosnier, Alexandre
    Lagarce, Laurence
    Garnier, Anne-Sophie
    Briet, Marie
    CANCERS, 2023, 15 (07)
  • [37] Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: evidence transporting from the rheumatoid arthritis population
    Montez-Rath, Maria E.
    Lubwama, Robert
    Kapphahn, Kris
    Ling, Albee Y.
    LoCasale, Robert
    Robinson, Lacey
    Chandross, Karen J.
    Desai, Manisha
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (08) : 1431 - 1437
  • [38] REAL-LIFE STUDY OF IMMUNOGENECITY AND SAFETY OF THE RECOMBINANT VACCINE AGAINST VARICELLA ZOSTER VIRUS IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH JANUS KINASE INHIBITORS
    Vazquez, A. V. Esteban
    Steiner, M.
    Castaneda, E.
    Vasallo, I. Thuissard
    Vazquez, C. Andreu
    Somodevilla, A.
    Yubero, C. Garcia
    Munoz-Fernandez, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2031 - 2032
  • [39] Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort
    Gentileschi, Stefano
    Gaggiano, Carla
    Damiani, Arianna
    Coccia, Carmela
    Bernardini, Pamela
    Cazzato, Massimiliano
    D'Alessandro, Francesco
    Vallifuoco, Giulia
    Terribili, Riccardo
    Bardelli, Marco
    Baldi, Caterina
    Cantarini, Luca
    Mosca, Marta
    Frediani, Bruno
    Guiducci, Serena
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [40] Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry
    Russo, V.
    Bianchi, V.
    Cavallaro, C.
    Vecchione, F.
    De Vivo, S.
    Santangelo, L.
    Sarubbi, B.
    Calabro, P.
    Nigro, G.
    D'Onofrio, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (20) : 3961 - 3967
12345